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ABSTRACT A new proprietary de novo peptide design technique generated ten 15-residue peptides targeting and containing
the leading nontransmembrane hydrophobic autocorrelation wavelengths, ‘‘modes’’, of the human m1 muscarinic cholinergic
receptor, m1AChR. These modes were also shared by the m4AChR subtype (but not the m2, m3, or m5 subtypes) and the three-
ﬁnger snake toxins that pseudoirreversibly bind m1AChR. The linear decomposition of the hydrophobically transformed
m1AChR amino acid sequence yielded ordered eigenvectors of orthogonal hydrophobic variational patterns. The weighted sum
of two eigenvectors formed the peptide design template. Amino acids were iteratively assigned to template positions randomly,
within hydrophobic groups. One peptide demonstrated signiﬁcant functional indirect agonist activity, and ﬁve produced
signiﬁcant positive allosteric modulation of atropine-reversible, direct-agonist-induced cellular activation in stably m1AChR-
transfected Chinese hamster ovary cells, reﬂected in integrated extracellular acidiﬁcation responses. The peptide positive
allosteric ligands produced left-shifts and peptide concentration-response augmentation in integrated extracellular acidiﬁcation
response asymptotic sigmoidal functions and concentration-response behavior in Hill number indices of positive cooperativity.
Peptide mode speciﬁcity was suggested by negative crossover experiments with human m2ACh and D2 dopamine receptors.
Morlet wavelet transformation of the leading eigenvector-derived, m1AChR eigenfunctions locates seven hydrophobic
transmembrane segments and suggests possible extracellular loop locations for the peptide-receptor mode-matched,
modulatory hydrophobic aggregation sites.
A BRIEF DESCRIPTION OF THE CONTEXT FOR
THE DEVELOPMENT OF ALGORITHMS FOR
RECEPTOR-TARGETED PEPTIDE DESIGN
One-dimensional amino acid sequence
pattern analyses
Our laboratory uses one-dimensional, algorithmic signal
processing approaches to polypeptide and protein sequence
analyses (Mandell, 1984; Mandell et al., 1987, 1997a,b,c,
2000a,b; Selz et al., 1998) and derivative membrane protein-
targeted peptide design methods (Mandell et al., 1998a,
2003). These methods have historical roots in Sanger’s
observation that the uniqueness of polypeptides and proteins
lie in their one-dimensional sequence of amino acids
(Sanger, 1952), and Anﬁnsen’s conclusion that all the
information determining the structure and function of
proteins is encoded in the potentially quantiﬁable physical
and chemical properties of their amino acid sequences
(Anﬁnsen, 1973). Our one-dimensional signal processing
approach to physical property-transformed amino acid
sequences includes the use of wavelet transformations,
maximum entropy power spectral transformations, multiple
‘‘ergodic’’ entropic measures, and linear decompositions of
lagged autocovariance matrices.
Since the introduction of this work, a number of other
laboratories have begun to use similar methods of analyses of
physical property-transformed amino acid sequences (Giu-
liani et al., 2003, 2000, 2002; Hirakawa et al., 1999; Lio and
Vannucci, 2000; Murray et al., 2002; Rackovsky, 1998).
Related matrix methods for sequential pattern ﬁnding have
been extended to predictions of transmembrane protein
structure from nucleotide sequences (Krogh et al., 2001). No
others have exploited these techniques for receptor-targeted
peptide design. We have recently been granted a United
States patent for these and related algorithmic receptor-
targeted peptide design methods (Algorithmic Design of
Peptides for Binding and/or Modulation of the Functions of
Receptors and/or Other Proteins, United States Patent No.
6,560,542, May 6, 2003).
The use of one-dimensional signal processing techniques
to reveal patterns in apparently disordered numerical
sequences has a long history in ﬁelds as diverse as
econometrics and meteorology (Bendat, 1958; Box and
Jenkins, 1970; Wold, 1965; Yaglom, 1962). More recently
this approach has included ﬁnding indices of order in
apparently disordered, deterministic, chaotic series of
quantitative observations (Broomhead et al., 1987; Broom-
head and King, 1986; Ott et al., 1994), including biological
applications (Guevara et al., 1981; May, 1974), a ﬁeld with
which we have had some experience (Mandell and Russo,
1981; Mandell and Selz, 1997; Russo and Mandell, 1984;
Selz and Mandell, 1991; Selz et al., 1995).
This work uses signal processing techniques in the
analyses and design of peptide ligands targeting the human
m1 cholinergic, G-protein coupled, seven-transmembrane
receptor. These forms of pattern analyses require the
transformation of amino acid sequences into numerical
series. To do so, we must ﬁrst choose among quantiﬁable
amino acid physical properties relevant to peptide-protein,
noncovalent interactions in aqueous solution. Candidate
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physical properties include van der Waals forces, potential
for interactions between charged groups, possible relations
between the hydrogen bonds of polar groups, and the
availability for interactions between nonpolar groups in
water, called hydrophobic aggregation (Israelachvilli, 1992).
Choice of a physical quantity for amino acid
sequence transformation
Van der Waals interactions occur between aqueous poly-
peptide groups aswell as between these groups andwater. The
two components are estimated to contribute about equally,
and therefore, do not produce a signiﬁcant net effect in the
stabilization of aqueous polypeptide-polypeptide interac-
tions, as in peptide ligand binding or the initial phases of
protein folding (Chalaskinski and Szczesniak, 1994; Makha-
tadze and Privalov, 1993; Privalov, 1987). Amino acid
charged groups are statistically relatively rare (Creighton,
1993), and their interactions are shielded by the high dielectric
constant, aqueous surround (Bashford andCase, 2000; Ptitsyn
et al., 1995; Stillinger, 1977). They are, therefore, assumed to
play only a small role in the stabilization of polypeptide
interactions (Privalov, 1989; Privalov and Gill, 1988).
However, they may play some role in spatially directing the
initial phases of protein folding and, analogously, peptide-
receptor aggregation (Shoemaker et al., 1997).
Hydrogen bonding occurs between protein polar groups
and between these groups and water molecules, leading to
only a small net contribution to polypeptide interactional
stability (Caﬂisch andKarplus, 1994;Yang andHonig, 1995).
A study of 80 crystallographically characterized protein-
ligand complexes, many binding within the nanomolar range,
demonstrated no hydrogen bonds between the protein and the
ligand. There was, however, a good correlation between
lipophioic contact surface in angstroms squared (A˚2) and the
negative logarithm of their Ki values (Bohm and Klebe,
1996). In addition, using our design algorithms, we have
found that the physiologically active, m1-targeted peptides
appear to require a restricted range of average amino acid side-
chain pKa values of 7.2–7.8 (Table 4, bottom). In addition,
our recent work indicates that the probability of producing
physiologically active autocovariance eigenvector template-
generated, de novo peptides can be increased by considering
the sequential pattern of receptor sequence’s amino acid side-
chain pKas (as represented in the relevant pKa autocovariance
eigenvector) in the choices of amino acid assignment within
its hydrophobic group to the corresponding four-partitioned
hydrophobic free-energy eigenvector template (see below for
explanatory details).
A commonly held hypothesis is that the greatest source of
energy for attractive stabilization of polypeptide-polypeptide
or peptide-protein interactions comes from the hydrophobic
interactions between the nonpolar groups of amino acid
polymers in water (Ben-Naim, 1980; Israelachvili, 1992;
Tanford, 1980). This is consistent with more than a half
century of work, beginning with Edsall’s 1935 observation
of an anomalous increase in the molar heat capacity of water
in the presence of nonpolar solutes (Edsall and Wyman,
1958), and Franks and Evans (1945) related thermodynamic
observations that nonpolar solutes increase the order
(decrease the entropy) of water (Franks, 1972). The decrease
in entropy that occurs with the transfer of nonpolar groups
into water is thermodynamically unfavorable, such that the
aqueous system tends to expel these molecules. The
expelling action of water on nonpolar groups leads them
to aggregate, minimizing their surface area, and this came to
be regarded as the general deﬁnition of hydrophobic inter-
actions between nonpolar molecules (Kauzmann, 1959;
Tanford, 1980). Hydrophobic attraction as measured by
atomic force spectroscopy remains signiﬁcant at distances
$20 nanometers, and decays more slowly than van der
Waals forces with distance (Israelachvilli, 1992; Tsao et al.,
1993). These considerations led naturally to our choice of
relative amino acid side-chain hydrophobicity as the amino
acid parameter for numerical transformation of the targeted
G-protein coupled receptor’s (GPCR’s) sequences, their
analyses and the design of GPCR-targeted de novo peptides
(Mandell et al., 1998a, 2003).
Choices among and some physical correlates
of hydrophobicity scales
There are a large number of experimentally derived
numerical scales quantitatively ordering the 20 essential
amino acids’ relative hydrophobicity in an aqueous environ-
ment. Among them are a variety of binary solvent partitions
(Cornette et al., 1987; Fauchere and Pliska, 1983; Manavalen
and Ponnuswamy, 1978; Nozaki and Tanford, 1971) and
relative vapor ! water concentrations (Kyte and Doolittle,
1982; Radzicka and Wolfenden, 1988) (see http://pref.
etfox.hr./split/scales.html for a relatively complete reference
listing with methods used and physical properties quantiﬁed
leading to 88 hydrophobicity scales). Our computations have
demonstrated that interscale correlations ranged from r ¼
0.579 to r ¼ 0.918, using a variety of representative solvent
partition and vapor pressure determined hydrophobicity
scales. Another aqueous solvent-dependent amino acid
side-chain property, accessible surface area, in A˚2, correlated
r ¼ 0.56 with the (Eyring-Tanford-Zimmerman) Tanford
hydrophobicity scale (Manavalen and Ponnuswamy, 1978)
used in these studies. Accessible surface area may be an
important physical property with respect to the problem of
polypeptide aggregation and binding (Chothia, 1974; Dyson
and Wright, 2002a; Huntly et al., 2003). Partial speciﬁc
volume, in A˚3, (Zamyatnin, 1984) and van der Waals volume
(volume enclosed by van derWaal radius), in A˚3, (Creighton,
1993) correlated with the Tanford hydrophobicity scale as
r ¼ 0.67 and r ¼ 0.72, respectively. The covariation of these
properties with the Tanford hydrophobicity scale suggests
that the hydrophobic scale, as we have used it, may also
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partially address one or more of these hydrophobicity-related
properties. Whereas the magnitude of the hydrophobic ef-
fect, as measured from the surface area dependence of the
solubilities of hydrocarbons in water, has generally been
reported to be ;25 calories/mol/A˚2, more recent work tak-
ing surface tension at a hydrocarbon-water interface into
consideration (Sharp et al., 1991a,b) results in higher
estimates of 47 calories/mol/A˚2.
Our research program has used the Tanford scale from the
beginning (Mandell, 1984) (Manavalen and Ponnuswamy,
1978) due to its historical precedence, relatively high
correlation with most other hydrophobicity scales as well
as with other amino acid physical properties, and our pre-
vious successes using it in our peptide design algorithms
(Mandell et al., 2003). Particularly useful is the Tanford
scale’s nonarbitrary, four-part partition of the values it gives
to the 20 essential amino acids (Manavalen and Ponnu-
swamy, 1978). These fall into correspondence with the four-
partitioned autocovariance eigenvector templates, key
elements in our peptide design algorithms.
Proline, which individually partitions with the Tanford
scale’s most hydrophobic group, behaves like glycine with
respect to its inﬂuence on secondary structure in x-ray studies
of amino acid sequences (Deber et al., 1990; Gunasekaran
et al., 1998). Glycine is a member of the Tanford scale’s least
hydrophobic group. Both are known to disrupt membrane
protein secondary structure (Nilsson and von Heijne, 1998;
von Heijne, 1991), including turn propensity (Monne et al.,
1999) and loops (Duerson et al., 1993; Fetrow et al., 1998).
For this reason, we code proline like glycine (0.0 kcal/mol) in
the lowest of the natural clusters constituting the four amino
acid hydrophobicity groups.
The amino acid sequence of the human m1 muscarinic
cholinergic receptor was obtained from the SWISS-PROT
protein sequence data bank. The amino acid hydrophobic
free energies in kcal/mol used in these studies divide
naturally into four groups (with the above noted proline
‘‘secondary structure breaking’’ correction): 1),G¼ 0.0, P¼
0.0, Q ¼ 0.0, S ¼ 0.07, T ¼ 0.07, N ¼ 0.09; 2), D ¼ 0.66,
E ¼ 0.67, R ¼ 0.85, A ¼ 0.87, H ¼ 0.87; 3), C ¼ 1.52, K ¼
1.65, M ¼ 1.67, V ¼ 1.87; and 4), L ¼ 2.17, Y ¼ 2.76, F ¼
2.87, I ¼ 3.15, W ¼ 3.77, providing the natural four
partitions mentioned above (Manavalen and Ponnuswamy,
1978). These values will be referred to as the Tanford scale.
Sequential patterns, v21, in hydrophobicity and
secondary structures
Helical turns and b-strands and turns are the best established
hydrophobic rotations based on x-ray and NMR evidence of
secondary structure, with modes of v1 ¼ 3.6 amino acids
(aa), 2.2 aa, and 2.0 aa, respectively (Eisenberg et al., 1984;
Irback et al., 1996; Irback and Sandelin, 2000; Lazovic,
1996; Milner-White and Poet, 1987; Penel et al., 1999; Rose,
1978; Rose and Wetlaufer, 1977; Schiffer and Edmundson,
1967) (see Table 1).
The autocovariance eigenvector modes represent, in effect,
a hierarchy of secondary structural, noisy, semiperiodically
recurrent, hydrophobic variational wavelengths, v1. Our
studies of neuropeptides and their receptors have demon-
strated dominant hydrophobic wavelengths ranging from
v1 ¼ 2.06 in porins, connexin, and other proteins
dominated by up and down antiparallel b-structures (Selz
et al., 1998), and v1 ¼ 2.18 aa in corticotropin releasing
hormone, to v1 ¼ 13.6 aa in acid ﬁbroblastic growth factor
in hormonal and neuropeptides (Mandell et al., 1987) to
v1 $ 50–701 aa in subsequences containing the trans-
membrane segments of GPCRs (Mandell et al., 1997c). Other
examples of dominant hydrophobic wavelengths in protein
sequences include: the AIDS viral coat protein manifesting
a waxing and waning of hydrophobicity with v1 ¼ 7–9 aa,
a pattern which was conserved across several mutations
(Mandell et al., 1987); eigenmodes of representative Ig l-, k-,
and g-chains of v1 ¼ 12.5–13.7 aa (Mandell et al., 1997c);
peptide antagonists of the estrogen receptor (Norris et al.,
1999) and the ERa estrogen receptor that share a dominant
v1 ¼ 8.3 aa indexed mode (Mandell et al., 2000a); the
chaperone GroEL of b-lactamase (Gething, 1997) and
b-lactamase, both of which contain leading hydrophobic
eigenmode wavelengths of v1¼ 16.25 aa, 4.53 aa, and 2.11
aa (Mandell et al., 2000a). Differences in physical length, as
translations of computationally derived hydrophobic varia-
tions as wavelengths, are implied by the range of values for
the average ‘‘Translation per mode in A˚’’ seen in the last
column in Table 1. These values were computed from amino
acid ‘‘Residues per turn’’ and ‘‘Translation per residue’’ from
x-ray crystallographic data (Creighton, 1993).
The role of sequential hydrophobic patterns in peptide-
receptor interactions has been demonstrated in studies
showing that complete substitution of hydrophobically
equivalent amino acids in peptide hormones and neuro-
transmitters maintains and sometimes increases their pep-
tide-receptor mediated physiological potency (Blanc et al.,
1983; Fukushima et al., 1980; Kaiser and Kezdy, 1983; Lau
et al., 1983). Self-organizing helical secondary structures of
differing average rotational length can be designed with
sequences of amino acids that have been binary partitioned
TABLE 1 Hydrophobic modes: rotations and translations
Segment type
Residues per turn
(mode)
Translation per
residue (A˚)
Translation
per mode (A˚)
Antiparallel b 2.0 3.4 6.8
Parallel b 2.0 3.2 6.4
a-Helix 3.6 1.5 5.4
310 helix 3.0 2.0 6.0
p-Helix 4.4 1.15 5.06
Polyproline I 3.3 1.9 6.33
Polyproline II 3.0 3.12 9.36
Polyglycine II 3.0 3.1 9.30
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into high and low hydrophobicities, independent of the
speciﬁc amino acids being chosen within either hydropho-
bicity class (Kamtekar et al., 1993).
Intermolecular signaling by v21-matched
hydrophobic sequence attractive aggregation
With respect to the physical chemistry of the eigenmode-
matched peptide-protein attraction and aggregation, the
hydrophobic attractive force between hydrophobic moieties
is a function of surface area and radius of curvature, and can
be measured directly using techniques such as atomic force
microscopy (Israelachvili and Wennerstrom, 1996). The
hydrophobic attractive forces are generally two orders of
magnitude greater than those predicted from van der Waals
theory, and extend spatially in a slower-than-exponential
decay to beyond 20 nm (Pashley et al., 1985). The role of
hydrophobic mode matches in attractive aggregation has
been observed in the b-strands of interleukin 1b, which bind
together and initiate protein folding (Gronenborn and Clore,
1994) in a dynamic process called the ‘‘hydrophobic zipper’’
(Dill et al., 1993). Two long helical secondary structures with
congruent hydrophobic oscillatory wavelengths bind to form
the central ‘‘hydrophobic knot’’ that stabilizes the tertiary
structure of phospholipase A2 (Lumry, 1995). The binding of
extracellular domains of the growth hormone receptor by
polyclonal antibodies to bovine growth hormone is appar-
ently mediated by common sequential hydrophobic varia-
tional modes in helical, loop, and disordered secondary
structures (Beattie et al., 1996b).
Most of today’s approaches to rational peptide ligand
design, beyond the high throughput screening of randomly
generated peptide libraries (Zysk and Baumbach, 1998), are
dominated by pharmacophores, three-dimensional geometric
models of proteins’ putative active or regulatory binding
sites (Guner, 1999; Hruby and Agnes, 1999; Takeuchi et al.,
1998). The accelerating increase in the availability of x-ray
and NMR characterized three-dimensional structures of
proteins might seem to make the use of one-dimensional
sequential pattern analyses irrelevant for characterizing
peptide-targeted proteins. Polypeptide-protein and protein-
protein interactions of physically characterized structures are
explored using similar databases and docking algorithms
(Janin, 1995; Makino and Kuntz, 1997; Sandak et al., 1998;
Stahl and Bohm, 1998). However, an increasing number of
studies (Romero et al., 1998, 2001) have demonstrated
conformationally disordered polypeptide sequences, partic-
ularly relevant to the extracellular loops and juxta-trans-
membrane subsequences of GPCRs (the targets of our
hydrophobic mode targeting peptide design) (Dyson and
Wright, 2002a,b; Wright and Dyson, 1999). These sub-
sequences are without stable tertiary structure, as evidenced
by missing electron densities in x-ray crystallographic
studies, sharp peaks in NMRs, and/or the absence of
secondary structural nonlinear Overhauser effects and/or
circular dichroism spectroscopic examination with low
intensity signals from 210 to 240 nm (Romero et al.,
2001). Many of these disordered subsequences become
ordered upon ligand binding, going through a disorder-order
transition, achieving x-ray and NMR-demonstrable stable
tertiary structures (Dyson andWright, 2002a; Kriwacki et al.,
1996; Wright and Dyson, 1999).
Disordered protein subsequences may play signiﬁcant
roles in polypeptide-polypeptide and protein-protein inter-
actions, making them logical targets in rational peptide
design (Dunker et al., 1998, 2001; Dunker and Obradovic,
2001). The disordered loop subsequences of globular
proteins, 7 transmembrane segment GPCRs, and 12 trans-
membrane segment membrane transporters (Buck and
Amara, 1995; Nirenberg et al., 1997) participate in intra-
macromolecular signaling as active, allosteric, and antibody
binding sites (Bruccoleri et al., 1988; Howl and Wheatley,
1996; Lin et al., 1998;Milner-White and Poet, 1987; Qu et al.,
1999; Rondard and Bedouelle, 2000). They may also serve as
signal-invoked ‘‘switches’’, modulating access to active sites
(Branden and Tooze, 1999; Ulloa-Aguirre and Conn, 2000).
MODE SIMILARITIES OF PEPTIDE-TARGETED
SUBSEQUENCES OF MUSCARINIC
CHOLINERGIC RECEPTOR SUBTYPES
AND HYDROPHOBIC MODE-MATCHED
MUSCARINIC SNAKE TOXINS
As brief background, there are two classes of acetylcholine
receptors. Nicotinic acetylcholine receptors (nAChR) are
primarily found in the neuromuscular junctions and auto-
nomic ganglia of the peripheral nervous system, and are
cation-selective, ligand-gated ion channel membrane proteins
(Unwin, 1993; Wang et al., 2000). In contrast, the muscarinic
cholinergic receptors (mAChR) are G-protein coupled, seven
transmembrane receptors GPCRs. mAChRs have a 10-fold
higher concentration than nAChRs in the brain, and play
important roles in attention, arousal, cognition, learning, and
memory (Bartus et al., 1982; Flicker et al., 1985; Dickinson-
Anson et al., 1998; Fisher et al., 1993; Damasio et al., 1985;
Davis et al., 1992).
mAChR’s consist of ﬁve distinct subtypes, mi, i¼1,2, . . . 5,
categorized by dissimilarities in their amino acid sequences,
cholinergic drug-afﬁnities (Bonner, 1989; Bonner et al.,
1987; Buckley et al., 1989; McKinney and Coyle, 1991), and
differential regional and subcellular distributions in the brain
(Adem et al., 1997; Levey, 1996; Mrzljak et al., 1998).
Positional alignment of the amino acid sequences of the ﬁve
mAChR subtypes demonstrates that the greatest differences
in segment length occur in the extramembranous amino
acids, as well as the terminal carboxy and third intracellular
loop, i3. (Bonner et al., 1987; Liao et al., 1989; Numa et al.,
1988; Peralta et al., 1987). The greatest variability in amino
acid composition and side-chain sequential physical proper-
ties across mAChR subtypes also occurs in the extracellular
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loops (e1, e2, and e3) (Hulme, 1990; Hulme et al., 1991).
These are the sequence locations of computationally and
experimentally demonstrable and differential hydrophobic
mode speciﬁcities, reﬂected in the autocovariance eigenvec-
tor-generated peptides targeting m1AChR (and theoretically
the mode-equivalent m4AChR, but not m2AChR, m3AChR,
or m5AChR that evidence different dominant hydrophobic
modes).
The highly conserved, negatively charged aspartic acid
residue in the third transmembrane segment, TM3 (e.g., D-
105 in human m1AChR and D-111 in human m4AChR)
(Fraser et al., 1989; Hulme et al., 1995) is speculated to bind
to the characteristic positively charged headgroups of active
site-directed muscarinic ligands (Ehlert and Delen, 1990;
Kurtenbach et al., 1990). The hydrophobic, low dielectric
constant, membrane interior location of the putative active
site on TM3 is permissive of charge-charge interactions,
unlike the high dielectric constant, charge shielded aqueous
environments of the ei and intracellular loops, ii (Israelachvili
and Wennerstrom, 1996; Israelachvilli, 1992; Tsao et al.,
1993). We and others have speculated that aqueous environ-
ments facilitate the hydrophobic interactions of allosteric
and/or indirectly acting peptide ligands with extramembra-
nous portions, ei, of seven transmembrane receptors (Leck-
band et al., 1992, 1994; Mandell et al., 2003, 1997c, 2000a;
Richards and Richmond, 1977; Tucek and Proska, 1995).
Similarly, extracellular hydrophobic interactions with mus-
carinic GPCRs’ ei are thought to position three-ﬁngered
muscarinic snake toxins for their subsequent actions
(Jolkkonen et al., 1995; Olianas et al., 1999, 2000).
Noncompetitive modulators of mAChRs exert their
positive or negative effects on receptor afﬁnity and/or
efﬁcacy via interactions with away-from-the-active-site
locations (Birdsall et al., 1995; Jakubik et al., 1996;
Lazareno and Birdsall, 1996; Proska and Tucek, 1995). All
of the mAChR subtypes are subject to kinetic modulation by
a multiple and diverse group of ligands (Birdsall et al., 1997,
1983; Jakubik et al., 1997; Lanzafame et al., 1997; Lee and
el-Fakahany, 1991; Proska and Tucek, 1995). Studies using
point mutations and chimeral exchanges have indicated that
modulatory sites are subject to inﬂuence by hydrophobic
interactions that involve subsequences in ei and/or the
extramembranous vicinity of the TMi, i¼ 1. . .7 (Gnagey et al.,
1999; Matsui et al., 1995).
The polypeptide ‘‘ﬁngers’’ of themuscarinic three-ﬁngered
snake toxins bind in the same locations as the active site-
directed ligands, such as atropine and diphenylactoxy-N-
methylpiperidine (Jolkkonen et al., 1995; Olianas et al., 1999,
2000), but with much higher subtype speciﬁcity (Kukhtina
et al., 2000). The small differences in the dissociation
constants in –log(Kd) for atropine studied in murine
muscarinic receptor transfected ﬁbroblasts have been reported
as: m1 ¼ 9.29, m2 ¼ 9.00, m3 ¼ 9.28, m4 ¼ 9.66, and m5 ¼
9.43, and for diphenylactoxy-N-methylpiperidine, 4-DAMP,
m1¼ 8.92, m2¼ 8.21, m3¼ 9.19, m4¼ 9.15, and m5¼ 8.92
(Kashihara et al., 1992). The failure of these active site-
targeted small molecule cholinergic agents to discriminate
among muscarinic receptor subtypes contrasts with the high
selectivity of the m1 and m4 muscarinic receptor polypeptide
‘‘three-ﬁnger’’ snake toxins. The values of their inhibition
constants, Ki ¼ IC50/(11[L]/Kd) in nM of [3H]-N-methyl-
scopoline binding in human mAChR-transfected Chinese
hamster ovary (CHO) cells are: m1 ¼ 0.2–48.0 and m4 ¼
2–120 vs. m2, m3, and m5¼[1000–20,000, the members of
this snake toxin family being the most m1 and m4 receptor
selective ligands known. (Adem and Karlsson, 1997).
The amino acid sequence analyses and GPCR-targeted,
modulatory peptide designs presented here focus on the
sequential hydrophobic patterns that are statistically domi-
nant after the hydrophobic variation due to the trans-
membrane segments is computationally removed. m1AChR
and m4AChR were found to share ‘‘hydrophobic modes’’
that differed from those evidenced in the m2, m3, and m5
subtypes (see Table 3). The modes shared by the m1 and m4
muscarinic cholinergic receptors were also dominant in the
family of three-ﬁngered muscarinic snake toxins which bind
with speciﬁcity to those receptor subtypes (see Table 2).
SEQUENTIAL MODE ANALYSES IN THE
HYDROPHOBICALLY TRANSFORMED AMINO
ACID SEQUENCE OF M1ACHR: BACKGROUND,
METHODS AND FINDINGS
Patterns of hydrophobic variation in
secondary structure
It has long been known that sequential patterns in amino acid hydrophobic
variation, recurrent patterns we call hydrophobic modes, can contribute to
the prediction of secondary and supersecondary structures and their
interactions in globular and membrane proteins (Chothia, 1975; Chothia
and Janin, 1975; Chou and Fasman, 1974a,b; Cornette et al., 1987; Rose,
1978; Rose and Roy, 1980; Rose and Wetlaufer, 1977; Schiffer and
Edmundson, 1967). These patterns have been characterized using a variety
of descriptions of sequential hydrophobic variation, sometimes including
smoothing by nearest neighbor averaging of amino acid hydrophobicities
(Kyte and Doolittle, 1982). Among the best known of the hydrophobic mode
descriptors are Edmondson’s amphipathic helical wheel (Kaiser and Kezdy,
1983; Schiffer and Edmundson, 1967), Eisenberg’s hydrophobic moments
(Eisenberg et al., 1984), Rose’s chain turns (Rose, 1978), Skolnick’s b-turns
(Godzik and Skolnick, 1992), and Fourier and wavelet transformations in
hydrophobic wavelengths (Eisenberg et al., 1984; Giuliani et al., 2000,
2002; Hirakawa et al., 1999; Lazovic, 1996; Lio and Vannucci, 2000;
Mandell, 1984; Mandell et al., 1987, 1997a,b,c; Murray et al., 2002;
Rackovsky, 1998; Selz et al., 1998).
Our ﬁndings suggest hydrophobic mode-selective attractive aggregation
between polypeptide ligands and ei, juxta-TMi receptor, and other
subsequences containing matching modes (e.g., chaperone-protein binding)
(Mandell, 1984; Mandell et al., 1998a, 1987, 1997c, 2000a,b). As noted
above, these phenomena appear analogous to the self-aggregation of
sequential, amphipathically matching amino acid sequences in a process
called ‘‘hydrophobic zippering’’ (Dill et al., 1995, 1993; Gronenborn and
Clore, 1994), a process hypothesized to initiate folding in many proteins.
Similarly, helical bundle formation is known to occur along the long axes of
amphipathic helices with matching hydrophobic modes (Gibney et al., 2000;
Park et al., 2000; Shu et al., 2000).
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Characteristic wavelengths of hydrophobic
recurrence (modes) in polypeptides
Generalizing the above suggestive relationships between patterns of
hydrophobic variation and x-ray determined secondary structures in
proteins, and exploiting the evolutionary statistical stationarity of poly-
peptide and protein sequence structure that justify the use of signal
processing techniques on short series lengths, our laboratory used methods
including Fourier and moving window Fourier transformations to elucidate
familial mode commonalities in hormonal and neural peptides (Mandell,
1983, 1984, 1986, 1987; Mandell et al., 1987). For instance, a family of
trophic peptide hormones with\50% sequence homology, growth hormone
releasing factor, glucagon, vasoactive intestinal peptide, PHI, somatoliberin,
and the A-chain of insulin, were found to share a dominant hydrophobic
mode of v1 ¼ 4.0 aa wavelength (Mandell et al., 1987). Attempts to ﬁnd
mode matches by applying these techniques to the[400-aa-long sequences
of their and other membrane receptors were only occasionally successful; for
example, there appeared to be mode matches between several nicotinic
cholinergic toxins and nicotinic cholinergic receptors in the electric organ of
the Torpedo ray. Generally, however, even the 50-residue windowed
moving Fourier power spectra of the hydrophobic transformed sequences of
receptor sequences were ambiguous. The spectra were dominated by the
high amplitude, long wavelength, v1  50–701 aa variation of the highly
hydrophobic transmembrane segments. The spectra were noisy, with
difﬁcult-to-localize broadband peaks, manifesting end effects and often
multiperiodic. All of these problems made an examination for peptide ligand
and receptor hydrophobic mode matches difﬁcult.
Orthogonal mode decomposition augments power
spectral techniques in elucidating hydrophobic
modes in GPCRs
The evolutionary stationarity of what would otherwise be considered too-
short GPCRs aa series length for statistical treatment, the Wiener-Khinchine
relations (Bendat and Piersol, 1986) associating the correlation and spectral
density functions (with spectra already found promising for characterizing
hydrophobic modes in shorter hormonal and neuropeptide series), and the
need to deal with the sources of poor mode deﬁnition listed above, led
naturally to the selection of techniques derived from principle component
analyses (Fukunaga, 1990). These methods involve the linear decomposition
of correlation matrices and allow the computational removal of the dominant
transmembrane hydrophobic pattern, the discrimination of the remaining
leading modes from the noise ﬂoor, and the isolation of the leading
orthogonal modes from each other in potentially multimodal patterns. Being
without end effects and other potential limitations of ﬁxed transforms (e.g.,
of Fourier or Bessel), these transformations individually tailor the ‘‘shape’’
of the mode representation to the speciﬁc data series (in the form of the
leading eigenvectors, Xi, of the series’ lagged autocovariance matrices)
(Brillinger, 1981; Broomhead et al., 1987; Broomhead and King, 1986). In
the following, please notice that the computationally derived hydrophobic
mode(s) of GPCRs are represented in most detail by the leading
eigenvectors, Xi, singular or summed, of the lagged autocovariance matrix
transformation of the original hydrophobic series (Broomhead et al., 1987;
Broomhead and King, 1986; Golub and Van Loan, 1993) (see below). They
are represented more generally by an approximating index, v1 in aa, by the
maximum entropy, all-poles power spectral transformations (which picks
out one or two leading v-values) (Press et al., 1988) of the leading Xi or of
a constructed new smoothed function formed by the serial composition of Xi
with the original amino acid hydrophobic series to form an eigenvector-
weighted nearest neighbor-averaged autocovariance matrix eigenfunction,
ci (Broomhead et al., 1987; Broomhead and King, 1986).
Methods of lagged autocovariance matrix
formation, eigenvector extraction, and
autocovariance matrix eigenfunction construction
from m1’s hydrophobic series
The hydrophobically transformed amino acid sequences were used to
generate an M-lagged data matrix from which M 3 M covariance matrices,
CM, were computed. These CM were decomposed into sets of l orthogonal
eigenfunctions, cl(j), l ¼ 1. . .M, j ¼ 1. . .n  M11 (Broomhead et al., 1987;
Broomhead and King, 1986; Golub and Van Loan, 1993).
More speciﬁcally, from the sequentially lagged data column vectors (T[
transpose) V1
T¼ (H1, H2 . . . ,Hn  M ), V2T¼ (H2, H3 , . . . ,Hn  M 1 1), . . .,
VM
T ¼ (HM, HM 1 1, . . .,Hn ) and where K ¼ n  M 1 1, the sequence-
averaged dyadic product, Hi Hi
T is used to obtain the autocovariance matrix,
a HermiteanM3M matrix, CM ¼ 1/K{Hi HiT}.M ¼ 15 was chosen for the
m1 muscarinic cholinergic receptor to minimize the least-squares error of
m1’s leading c1, representing the pattern of the highly hydrophobic
transmembrane segments, and the m1 receptor’s nearest neighbor-smoothed
hydropathy plot, which is also dominated by the transmembrane pattern
(Kyte and Doolittle, 1982). We compute the ordered eigenvalues, {ni}i ¼
1. . .M, and the associated ordered eigenvectors, Xi(j), of CM , where i¼ 1. . .M
and labels the eigenvector, and j¼ 1. . .M and refers to the jth components of
the eigenvector Xi. The {ni}i ¼ 1. . .M are ordered from largest to smallest and
constitute the eigenvalue spectrum of CM. The similarly ordered associated
Xi(j) are convolved with original hydrophobic series into their associated
eigenfunctions cl(j), where l¼ 1. . .M labels the eigenvector and j¼ 1. . .n
M indexes the eigenfunction’s jth component. That is, the convolution of
each of the leading eigenvectors with the hydropathy series is carried out by
computing the sums of the scalar products of the M length eigenvector with
an M length of the hydrophobic series to produce a point in the
eigenfunction; this process is translated down the data series by one step
and repeated to generate each of the sequential points of the eigenfunction
that corresponds to its ordered eigenvalue-associated eigenvector in the
computation. In those studies, the cl of M are plotted as a function of the M
lag-reduced sequence position.
TABLE 2 Dominant hydrophobic wavelengths of snake muscarinic toxins
MT-1 MT-2 MT-3 MT-4 MT-5 MT-7 MT-a MT-b
2.59, 7.69 2.79, 8.36 7.70, 2.76 2.59, 7.83 2.73,7.72 2.51, 7.59 2.60, 7.63 2.61, 7.81
TABLE 3 Hierarchy of hydrophobic wavelengths in miAChR
Receptor
Ci, I ¼ 1. . .15 m1 m2 m3 m4 m5
1 ;73 ;90 ;90 ;74 ;66
2 7.78 2.00 3.14 40 8.66
3 7.74 8.70 11.05 7.04 2.00
4 2.42 8.57 11.62 7.84 7.94
5 2.43 5.06 3.12 2.37 3.96
6 12.05 13.89 2.56 4.69, 2.44 3.87
7 5.73 14.01 2.60 4.71 14.08
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Intuitively, CM scans for hydrophobic modes across a range of
autocorrelation lengths from 1 to M, the range of the lags deﬁned in the
original data matrices and reﬂected in the autocovariance matrices. Because
CM is real, symmetric and normal (CMCM
T ¼ CMTCM), its {ni}i ¼ 1. . .M are
real, nonnegative, and distinct, and its associated Xi(j) constitute a natural
basis for orthonormal projections on m1’s hydrophobic series (Golub and
Van Loan, 1993). The set of cl can be regarded as orthonormally
decomposed sequences of eigenvector-weighted, moving average values
(Broomhead et al., 1987; Broomhead and King, 1986).
All-poles maximum entropy power spectral
transformation of the leading eigenfunctions
The cl were transformed into their dominant hydrophobic modes (inverse
frequencies, v1) using all-poles maximum entropy power spectra, Sv(cl)
(Madan, 1993; Press et al., 1988)). Generally, SðvÞ ¼ a0=j11Sk¼1...M
ak expðikvÞj2; such that the zeros of the denominator result in peaks
(‘‘poles’’) marking the dominant hydrophobicmode(s) of thecl. This form of
the Fourier transformation generates relativelywell-resolved spectral peaks in
ﬁnite series in which only a small number, k, of the (auto)covariance
coefﬁcients, ck, are known. In these studies, k# 8 to avoid ‘‘splitting’’ S(v)
into spurious modes. The Fourier coefﬁcients, ak , can be calculated from the
set of data-derived ck, chosen so that the entropy of the spectral estimate, h¼R
lnSðv1Þdv, is maximal. Beyond the limited information of the small set of
data-derived autocorrelation-matched Fourier coefﬁcients, called the ‘‘cor-
relation matching property’’, the process is extended into a Gaussian process
such that h is maximized. It is known that the Gaussian is the function that
maximizes h under the constraints of a ﬁnite number of second order ck, as in
our data (Madan, 1993). Intuitively, the all-poles maximum entropy S(v)
yields results like an autoregressive, maximum likelihood spectral estimate in
that it is not model-dependent, but rather its ak values follow from the ck
values that are derived directly from the data (Priestly, 1981). This technique
acts as a ﬁltering process, yielding the moduli of the one or two leading
complex poles of discrete hydrophobic variational frequency in minimally
distorted form from the leading cl of the lagged autocovariance matrix of the
m1 sequence (Mandell et al., 1998a, 1997a,b,c; Selz et al., 1998).
The transmembrane mode as an example: the
leading eigenfunction, c1, of the m1 lagged
autocovariance matrix, CM, and its all-poles
power spectral representation, Sv(c1)
To exemplify the results of computational hydrophobic mode extraction, we
compare the standard m1 smoothed hydropathy plot with the X1 determined
(convolved with the original sequence) leading eigenfunction, c1, and its all-
poles power spectral transformation, representing the transmembrane mode
of the m1 muscarinic cholinergic receptor (Giuliani et al., 2002; Mandell
et al., 1998a, 1997c). Fig. 1 A is a plot of the hydrophobically transformed
amino acid series of m1 using the Tanford scale as listed above (Manavalen
and Ponnuswamy, 1978). Fig. 1 B is the all-poles power spectral
transformation of the hydropathy plot of Fig. 1 A evidencing its noisy
ﬂoor, broadband peaks, and multimodality, all of which make the isolation
and characterization of its hydrophobic modes not possible. Fig. 1 C was
computed by a nearest-neighbor, three-point moving average of the
hydrophobically transformed m1 amino acid sequence, iterated 11 times
and plotted as a function of the m1-11 length adapted from the approach of
Kyte and Doolittle (1982). Five-point moving averages iterated 11 times
were used to test the stability of the pattern of its hydrophobic oscillations.
Fig. 1 D is a graph of the all-poles power spectral transformation of Fig. 1 C
demonstrating its long wavelength of v1 ¼ 71.43 aa. Fig. 1 E is a graph of
m1’s c1 that very closely resembles the pattern of hydrophobic oscillations
of the transmembrane mode in the graph of Fig. 1 C. Fig. 1 F is a graph of the
all-poles maximum entropy power spectral transformation of m1’s c1,
indicating its long hydrophobic wavelength, v1 ¼ 73.15 aa. Note that the
spectrum of the leading eigenfunction differs by \2% in the frequency-
wavelength domain from that of the nearest neighbor-averaged hydropathy
plot (Fig. 1 D).
We graph the results of this computation of m1’s transmembrane mode to
exemplify the above outlined methods used in hydrophobic mode extraction
and characterization using the all-poles power spectra of the CM’s Xi-deﬁned
hierarchy of leading hydrophobic modes (Mandell et al., 2001, 1997c; Selz
et al., 1998). As described above, the maximum lag described in the
autocovariance matrix, here 15, determines the length of the eigenvalue-
weighted eigenvector(s) used as templates for amino acid assignment in
peptide design (see below). This value is chosen from a range of values so as
to maximize the correlation between the leading eigenfunction, c1 (Fig. 1 E),
and the nearest neighbor-averaged hydropathy plot (Kyte and Doolittle,
1982) (Fig. 1 C) (Mandell et al., 1997c).
Hydrophobic mode hierarchies in the family of
muscarinic cholinergic receptors, miAChR:
characteristic m1 and m4 modes
Using the methods illustrated above for the isolation and characterization of
the m1 transmembrane mode, Table 3 lists the all-poles power spectral
hydrophobic mode wavelengths v1 of the ordered leading eigenfunctions,
ci, of the ﬁve human miAChR subtypes. The m1 and m4 subtypes share
hydrophobic eigenfunction modes of v1  7.8 aa and 2.4 aa, neither of
which are present in the other three mAChR subtypes. Note that the closest
to these values of these three is the 7.94 aa mode of the m5 subtype. This m5
mode demonstrates a difference from the m1 target of[2% in the frequency-
wavelength domain (compare with \2% mode similarity comparing the
nearest neighbor-averaged and eigenfunction representations of the trans-
membrane mode). Two percent or less difference is our approximate criteria
for declaring mode frequency-wavelength similarities and differences.
Power spectral modes of the eigenfunctions associated with the 8th through
the 15th ordered eigenvectors are not shown. The receptors’ eigenvalue
spectra decayed quickly, and values of l7 through l15 were very small,
accounting for very little of the receptors’ variance in hydrophobic free
energy.
When a cell in Table 3 contains two entries—for example, the power
spectral peaks of c6 in m4—it is because a single eigenfunction, here c6,
evidenced the indicated two well-deﬁned peaks that were of nearly
equivalent power. The other kind of redundancy sometimes demonstrated
within a single receptor subtype results from isomodal eigenfunctions that
are out of phase and therefore orthogonal. In those cases, we see two
eigenfunctions with approximately the same statistical wavelength and
usually with similar eigenvalues and relative spectral power. An example of
this is also seen in Table 3, where the second and third eigenfunctions of
m1AChR (c2 and c3) manifest an isomodal, out-of-phase redundancy.
Generally in such cases, the eigenfunction associated with the slightly larger
eigenvalue is chosen in the construction of the receptor-targeted peptide
template.
As in our previous work (Mandell et al., 2003, 1997a,b,c, 1998b; Selz
et al., 1998), the dominant wavelengths of the power spectral modes of
m1AChR’s ci values were conﬁrmed and localized in the receptor sequence
with reference to the dominant mother wavelet scales and their sequence
locations using continuous, one-dimensional Morlet wavelet transforma-
tions (Farge et al., 1993; Strang, 1993; Wickerhauser, 1994). These
demonstrated that the sequence locations of the mother wavelet scale density
centroids corresponding to the 7.8 aa power spectral mode of c2 (and
isomodal but phase-advanced c3) were in the sequence vicinity of the
putative e1 and e3 extracellular loops. (See Fig. 3 B and associated discussion
below.) This ﬁnding is relevant to the modulatory role of hydrophobic mode
matches in these sequence locations because alanine mutagenesis of Tyr-101
and Tyr-404, in the e1 and e3 loops, respectively, resulted in the m1 allosteric
ligands, gallamine and himbacine, failing to bind and/or modulate the m1
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muscarinic receptor (Matsui et al., 1995). The ei are known to be common
locations for ligand-mimetic binding of antibodies raised to transmembrane
receptors (Beattie et al., 1996a,b). Molecular dynamics simulations of
protein motions show coupling between peptide chain loops (Watanabe
et al., 1997), and such modulation of loop movements can serve as
‘‘molecular switches’’ (Ma and Karplus, 1997) initiating conformational
transitions in some proteins (Lazaridis and Karplus, 1997).
Hydrophobic modes in a family of muscarinic
snake toxins: similarities with the characteristic
m1 and m4 leading hydrophobic modes
As an independent source of mAChR-matched hydrophobic modes, we
studied the family of 64–65 residue peptide toxins from the green and
black mamba snakes, Dendroaspis angusticeps and Dendroaspis polylepis
(Jerusalinsky et al., 1997; Jerusalinsky and Harvey, 1994). These toxins
have been shown to be selectively speciﬁc for the m1 and m4, but not m2,
m3, or m5 AChR subtypes. They manifest long-lasting ‘‘pseudoirrever-
sible’’ allosteric modulation of muscarinic antagonist binding (Adem et al.,
1997; Adem and Karlsson, 1997). The leading hydrophobic modes of the
all-poles power spectral transformation of these relatively short, 64–65
residue hydrophobically transformed amino acid series are listed in Table
2. Because of their short lengths and the absence of TM associated
modes, the toxins did not require eigendecomposition of their autocovar-
iance matrices. MT-1 through MT-7 are m1AChR and m4AChR subtype
speciﬁc muscarinic toxins isolated and sequenced from the venom of the
green mamba (Adem and Karlsson, 1997; Olianas et al., 2000). MT-a and
MT-b were isolated and sequenced from the venom of the black mamba
snake (Adem and Karlsson, 1997; Jerusalinsky et al., 1997; Olianas et al.,
2000). Note how the two dominant hydrophobic modes of the m1 and m4
speciﬁc snake toxins approximate the dominant modes found in the
posttransmembrane hydrophobic modes of the m1 and m4 receptors (Table
3). We note that these hydrophobic modes are not generic for all three-
ﬁngered toxins in that all of the members of the three-ﬁngered nicotinic
acetylcholine receptor-targeted toxins of sea kraits demonstrate dominant
hydrophobic wavelengths of 2.0 and 4.15 aa (Housset and Fontecilla-
Camps, 1996).
FIGURE 1 (A) Plot of the hydro-
phobically transformed amino acid se-
ries of m1AChR using the Tanford scale
(kcal/mol). (B) All-poles power spectral
transformation of the series in A. A is an
undecomposed sequence and results in
a noisy, multimodal spectrum with
broadband peaks, complicating the iso-
lation and characterization of its hydro-
phobicmodes. (C) Results of an iterative
nearest-neighbor, three-point moving
average transformation of the hydro-
phobically transformed series in A. (D)
All-poles power spectral transformation
of the series shown in C, demonstrating
its dominant long hydrophobic wave-
length of v1 ¼ 71.43 aa. m1AChR’s
hydrophobically transformed series is
used to produce a sequentially lagged
data matrix. The autocovariance mat-
rix of this data matrix is computed and
its eigenvalues and eigenvectors are
derived. (E) m1AChR’s leading eigen-
function, c1, resulting from a linear
decomposition of its lagged autocovar-
iancematrix, after which the eigenvector
associated with the largest eigenvalue of
the autocovariance matrix is composed
with the original hydrophobic series
shown in A. Note that m1AChR’s c1
very closely resembles the pattern of
hydrophobic oscillations seen in the
nearest-neighbor hydropathy plot that
is known to be dominated by the pattern
of hydrophobic transmembrane seg-
ments (C). (F) All-poles, maximum
entropy power spectral transformation
of c1, indicating its long dominant
hydrophobic wavelength, v1 ¼ 73.15
aa, which differs by \2% in the
frequency-wavelength domain from that
of the nearest neighbor-averaged hydropathy plot (D). Maximum lag in the data matrix determines the dimensions of the autocovariance matrix and the length of
the eigenvectors and of the peptides built from the eigenvector template (see text). Here we chose that value to be 15, the value\25 that minimized least-squares
error in the ﬁt of c1 with the nearest neighbor-averaged hydropathy plot (C) to c1 (E).
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DESIGN OF M1ACHR-TARGETED PEPTIDES
USING LEADING EIGENVECTOR MODES AS
TEMPLATES FOR POSITIONAL ASSIGNMENT
OF AMINO ACIDS BY HYDROPHOBIC GROUP
This algorithmic approach to m1AChR-targeted peptide
design contrasts with many other rational peptide design
strategies that exploit geometric, active site models of
physiologically active peptides called ‘‘pharmacophores’’
(Hruby and Agnes, 1999; Takeuchi et al., 1998; Zysk and
Baumbach, 1998). These models are composed of three-
dimensional arrangements of molecular constituents with
potential noncovalent interactions, including hydrogen bond
donors and acceptors, ionizable groups, and ring or chain
hydrophobic aggregation. Models emphasize modular com-
ponents found to be common among similarly active agents.
These are often discovered by high through-put screening of
large peptide libraries (Guner, 1999).
In contrast, our sequence approach to the hydrophobic
mode characterization of GPCRs is uniquely relevant to
membrane protein subsequences that may be without stable
tertiary structure (Romero et al., 1998). As described above,
these conformationally disordered polypeptide sequences
evidenced in x-ray crystallographic studies by missing
electron densities, nuclear magnetic resonance graphs with
sharp peaks, and/or the absence of evidence for secondary
structure in nuclear Overhauser effects and circular di-
chroism studies with low-intensity signals from 210 to 240
nm (Dyson and Wright, 2002a,b; Romero et al., 2001;
Wright and Dyson, 1999). Such subsequences characteris-
tically become ordered upon ligand binding, going through
a disorder-order transition and achieving x-ray and/or NMR
demonstrable stable tertiary structure (Dyson and Wright,
2002a,b; Kriwacki et al., 1996; Wright and Dyson, 1999).
Recall that disordered loop sequences of globular proteins,
GPCRs, and 12 transmembrane segment transporters (Buck
and Amara, 1995; Nirenberg et al., 1997) have been shown
to play signiﬁcant roles in polypeptide-polypeptide and
protein-protein interactions, participating in allosteric and
antibody binding sites (Rondard and Bedouelle, 2000)
and modulatory ‘‘switches’’ (Ulloa-Aguirre and Conn,
2000). This makes them promising targets in rational peptide
ligand design (Dunker et al., 1998, 2001; Dunker and
Obradovic, 2001). We address these targets, using the
leading hydrophobic eigenvector(s), Xi, in mode-matched
polypeptide ligand design. In this way, we have successfully
targeted ‘‘away from the active site’’ GPCR modulatory
mechanisms in the D2 dopamine receptor (Mandell et al.,
2003; Naylor et al., 1995; Simpson et al., 1999; Vaughan
et al., 2001) and the nerve growth factor tyrosine kinase
receptor (Mandell et al., 2001). After computational removal
of the transmembrane mode (Fig. 1), the leading eigenvector
hydrophobic modes tend to be concentrated in putative
extracellular loop and juxta-transmembrane polypeptide
subsequences in membrane receptors (Mandell et al.,
1998a, 2003, 2001, 1997c). As noted above, our initial
studies using this approach to analyses found many
autocovariance matrix eigenvector-determined hydrophobic
mode matches between naturally occurring hormonal and
neuropeptides and their receptors (Mandell et al., 1998a,c).
Based on hydrophobic mode matches we have predicted
polypeptide-protein interactions later found in a chaperone
and its associated protein, as well as in peptide modulators of
the estrogen receptor and the receptor itself (Mandell et al.,
2000a).
The design process involves the use of the posttrans-
membrane, leading, lagged autocovariance matrix, eigen-
value-weighted eigenvector(s). These eigenvectors are four-
equipartitioned to correspond to the natural four clusters of
hydrophobicity in the Tanford scale, and used as templates
for amino acid assignment. Amino acid assignment is made
by group/partition as weighted by their probability of
occurrence (in each hydrophobic group) as measured in the
human brain’s extracellular ﬂuid (Perry et al., 1975). In the
study designing physiologically active peptides targeting
the tyrosine kinase-coupled, nerve growth factor tyrosine
kinase receptor (without the seven transmembrane mode of
GPCRs), the receptor manifested three orthogonal leading
eigenvector modes, X1, X2, and X3, which, being almost
equal in modular amplitude and linearly independent, were
combined in an eigenvalue-weighted sum to generate the
template for amino acid assignment (Mandell et al., 2001). In
designing the physiologically active D2DAR-targeted pep-
tides (Mandell et al., 2003), the transmembrane mode was
computationally removed. The two leading posttransmem-
brane hydrophobic modes were both found in c2, and the
associated X2 was used as the template for probability-
weighted amino assignment. After computational removal of
the transmembrane mode of m1AChR (Fig. 1, E and F), there
were two leading eigenvector modes remaining: one found in
c2, v
1 ¼ 7.78 aa (Fig. 2, A and B; Table 3) and its phase
shifted near redundancy in c3, v
1 ¼ 7.74 aa (Table 3). The
other was found in c4, v
1 ¼ 2.42 aa (Fig. 2, C and D)
and its phase shifted near redundancy in c5, v
1¼ 2.43 aa
(Table 3).
Based on these ﬁndings, the eigenvector template was
constructed from the sum of the second eigenvalue weighted
X2 (associated with c2) and the fourth eigenvalue weighted
X4 (associated with c4). This four-partitioned eigenvector m1
template (Fig. 2 E) was used in the design of the m1AChR-
targeted, 15 mer peptides as listed in Table 4. The template
sequence by partition section is listed, with lowest to highest
hydrophobicity group represented numerically as 1, 2, 3, and
4. As noted above, in each of the 15 template locations, an
amino acid representative of its matching hydrophobic group
was randomly assigned, as probabilistically weighted by its
(within group) occurrence in human brain extracellular ﬂuid
(Perry et al., 1975) (Fig. 2 E). Of the peptides computation-
ally generated by the iterative application of this procedure,
we selected the 10 amino acid sequences for synthesis to
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$95% purity (by mass spectrometry) by Multiple Peptide
Systems (La Jolla, CA) (Table 4) that manifested all-poles
power spectral wavelengths that deviated least from the
dominant wavelengths of c2 and c4 (Fig. 2, B andD) and the
muscarinic snake toxins (Table 2).
LOCATING PUTATIVE ALLOSTERIC SITES BY
REPRESENTING THE M1ACHR’S LEADING
EIGENVECTOR MODES AS MODULAR
DENSITIES IN THE MORLET WAVELET PLANE
Rhodopson, whose x-ray structure is now known at 2.8 A˚
resolution (Palczewski et al., 2000) is perhaps generalizable
to other GPCRs, but very little speciﬁc has been established
about the locations and characteristics of other GPCR’s
orthosteric or allosteric sites (Schwartz and Rosenkilde,
1996). Studies using point mutagenesis, chimeric exchanges,
and chemical modiﬁcations of putative sites have shown
a diversity of apparent orthosteric and allosteric binding
domains, including those within the transmembrane regions
(for many biogenic amines), those involving both trans-
membrane, TMi, and extracellular loop, ei, subsequences (for
some neuropeptides) and those in the N-terminal domain (for
some neuropeptides and metabotropic ligands) (Christopou-
los and Kenakin, 2002).
Unlike Fourier transformation, wavelet transformations of
hydrophobically coded protein receptor amino acid series
conserve information about both sequence location and
hydrophobic eigenmode wavelength (Daubechies, 1992;
Farge et al., 1993; Mallat, 1989; Wickerhauser, 1994). Using
discrete, best basis, trigonometric wavelet transformations,
we have conﬁrmed the power spectral leading eigenvector
mode matches of several opiate peptides with their receptors
and of somatostatin, bombesin, neurotensin, and cholecys-
tokinin with their receptors (Mandell et al., 1998a,c). The
matching modes were most dense in the sequence locations
FIGURE 2 (A and C) m1AChR’s second and
fourth hydrophobic free energy eigenfunctions,
c2 and c4, constructed by the composition of
the second and fourth largest eigenvalued
eigenvectors, X2 and X4, of its 15-lagged
autocovariance matrix, with the hydrophobic
series of the human m1 muscarinic receptor
(shown in Fig. 1 A). m1AChR’s third and ﬁfth
eigenfunctions, c3 and c5, were phase-shifted
versions of c2 and c4, respectively (see Table
3). The leading eigenfunction, c1, was domi-
nated by the pattern of seven transmembrane
segments (shown in Fig. 1, E and F). (B and D)
All-poles power spectral transformations of c2
and c4. Their dominant hydrophobic varia-
tional frequency peaks correspond to hydro-
phobic mode wavelengths of v2
1 ¼ 2.42 aa
and v4
1 ¼ 7.78 aa. (E) Eigenvector template
constructed as the eigenvalue weighted sum,
l2X2 1 l4 X4, where li are the autocovariance
matrix-ordered eigenvalues. The template was
four-equipartitioned to correspond to the amino
acids’ four hydrophobic groups. In the peptide
design process, speciﬁc amino acids are
assigned randomly within these groups, as dis-
tributionally weighted by within-group mem-
bership in the human brain’s aqueous amino
acid pool. E also indicates amino acid groups’
membership and their approximate within-
group probabilities of occurrence in human
cerebrospinal ﬂuid.
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of the receptor’s respective putative extracellular loops,
especially e2 and e3, and sometime their N-terminal
segments. Similarly, wavelet transformation of the hydro-
phobically transformed amino acid series of the long form,
D2 dopamine receptor suggested leading eigenvector
hydrophobic mode locations in the e2 and e3 regions
(Mandell et al., 2003), extracellular to the transmembrane
regions of the putative dopamine binding site (Dal Toso et al.,
1989; Kozell et al., 1994; Neve andWiens, 1995; Woodward
et al., 1994). Mode-targeted, eigenvector template-designed
peptides demonstrated signiﬁcant positive modulatory
effects on D2 dopamine receptor-transfected cellular func-
tion, as well as dramatically augmenting dopamine-mediated
behavior in the rat brain (Mandell et al., 2003).
Christopoulos and Kenakin (2002) have reviewed allo-
steric mechanisms using point mutagenic and chimeric
exchange studies in muscarinic receptors assessed by
isotopic ligand binding and cellular function. They suggest
that mi allosteric modulators such as gallamine, alcuronium,
and the bis-ammonium compounds have multiple extracel-
lular sites of action, particularly in the sequence neighbor-
hoods of the extracellular loops, e2 and e3 (Birdsall et al.,
1996; Christopoulos and Kenakin, 2002; Christopoulos et al.,
1998; Lee and el-Fakahany, 1991; Matsui et al., 1995).
Relevant to our program designing receptor-targeted,
hydrophobic mode-matched peptides, it is interesting that
antibodies raised to these extracellular loop polypeptide
sequences have been shown to allosterically modulate and/or
activate GPCRs (abu Alla et al., 1996; Mijares et al., 1996,
2000). In addition, studies using peptide fractions and/or
protease sensitive tissue extracts as well as speciﬁc peptides
such as dynorphin A have demonstrated allosteric actions on
GPCRs (Diaz-Arrastia et al., 1985; Heron and Schimerlik,
1984; Hu and el-Fakahany, 1993; Hu et al., 1992).
The relative paucity of known allosteric agents for
GPCRs, the current lack of knowledge about their sites of
action, and an absence of standard techniques for designing
them (beyond the use of high through-put screening of
random chemical libraries) may be explained in Christopou-
los’ and Kenakin’s comment that ‘‘. . . hormone or
neurotransmitter receptor allosteric sites may simply repre-
sent accessory domains normally serving structural roles and
it is only with the discovery of (functionally active)
exogenous ligands that recognize these domains that
allosteric modulation of receptor function becomes bio-
logically relevant . . .’’ (Christopoulos and Kenakin, 2002).
Graphs of the wavelet plane of continuous Morlet wavelet
transformations of hydrophobically transformed a-helical
proteins (e.g., myoglobin and hemoglobin), b-sheet proteins
(e.g., concancavalan A and prealbumin) and the mixed a/
b-proteins (e.g., carboxypeptidase and rhodanase) portrayed
the hydrophobic mode lengths (mother wavelet scales) and
sequence locations of their primary and secondary structures
(Mandell et al., 1997a,b). We can bring proteins’ hydropho-
bic wavelengths and those wavelength densities sequence
locations into clearer focus by linear decomposition of their
hydrophobically transformed protein sequences’ lagged
autocovariance matrices, and studying their leading eigen-
vector-generated autocovariance eigenfunctions using con-
tinuous Morlet wavelet transformation (Mandell et al.,
1997b). This sequence of transformations when applied to
the generic and historically best structurally characterized
transmembrane receptor, rhodopsin, located the seven
transmembrane segments in the amino acid sequence quite
well (Mandell et al., 1997b). Subsequent wavelet trans-
formation studies of proteins by others have conﬁrmed the
usefulness of wavelet transformations in the characterization
and localization of transmembrane segments, hydrophobic
cores in globular proteins, and repeating motifs (Hirakawa
et al., 1999; Lio and Vannucci, 2000; Murray et al., 2002;
Wouters et al., 2000).
Continuous Morlet wavelet transformations of m1AChR’s
c1 v
1¼ 73.15 aa, c2 v1¼ 7.78 aa, and c4 v1¼ 2.42 aa,
as deﬁned above, were undertaken using standard algorithms
(Daubechies, 1992; Farge et al., 1993; Mallat, 1989; Strang,
1993; Wickerhauser, 1994). Generally, a Morlet wavelet
transform, T(a,b), of a series of n eigenfunction values,
ciðnÞ, consists of decomposing the series into translated, f(n)
! f(n  b) and scaled, f(n) ! f(n)/a (scale is analogous to
the inverse radian frequency of a trigonometric function)
versions of the mother Morlet wavelet, w. w is the con-
tinuous, symmetric, inﬁnitely regular, modulated Gaussian
Morlet wavelet (Grossman and Morlet, 1984) wðnÞ ¼
1=
ﬃﬃﬃﬃﬃﬃ
2p
p
expðn2=2Þexpð2pifnÞ, and is composed with the
data series ciðnÞas: Tða; bÞ ¼ 1=
ﬃﬃﬃ
a
p R n
0
ciðnÞ wðn b=aÞdn:
Fig. 3, A–C, show the wavelet transformations of the
series of the indicated leading m1 eigenfunction. Sequence
position of the wavelet coefﬁcients is graphed along the x
axis and the relative wavelength scale is plotted along the y
axis. Empirically, the indicated scale divided by a little over
4 at the bottom, with the denominator decreasing toward just
over 2 at the top approximating the hydrophobic (mother
TABLE 4 Human cholinergic m1AChR targeted peptides
Sequence
Indirect agonist
effect
Modulatory
effect
H-FSFQCKSINYEALGY-OH ** ***
H-FSFGVKSWQYHALGY-OH ns *
H-ITFTVKGLTLAAFTY-OH ns ***
H-ISFNKCTWSFERYSL-OH ns *
H-FNLSVKQWNYRAYNL-OH ns **
H-LNYQKKQYTYAAWQF-OH ns ns
H-LTYGVMNYGFAAFGF-OH ns ns
H-LGFSVCPITLAELTY-OH ns ns
H-LGLGVCPINLAALTW-OH ns ns
H-LTWNVKTYSLHELPL-OH ns ns
m1 targeted peptide average side chain pKa (n ¼ active,  ¼ nonactive)
   
n n n n n
7 8
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Morlet wavelet) eigenfunction wavelength (Mandell et al.,
2001, 1997b,c, 1998b). The densities of the implicit z axis
portray the modular amplitude of the wavelet transformation
at the indicated scale and location, graphed in threshold
isopotential plots. Fig. 3 A is a graph of the continuous
Morlet wavelet transformation of c1, suggesting modular
peaks corresponding to m1AChR’s seven transmembrane
segments. Fig. 3 B is a graph of the Morlet wavelet
transformation of c2, with densities approximating a mother
wavelet wavelength corresponding to a hydrophobic wave-
length of7–8 aa, and which overlaps the putative sequence
locations of the N-terminal segment, e1 (75–100), e2
(155–180), and e3 (380–405) (SWISS-PROT, Version
41.19). This suggests, as reviewed above, the potential for
peptide hydrophobic mode matched interaction at these
speculated allosteric sites in GPCRs in general and m1AChR
in particular. Of course, the leading hydrophobic eigenvector
containing subsequences may be part of the transmembrane
receptor’s structural domains, assuming the role of allosteric
site only with experimentally demonstrable hydrophobic
mode matched modulatory actions (Christopoulos and
Kenakin, 2002) (see below). Fig. 3 C is a graph of the
Morlet wavelet transformation of c4, with a particularly
prominent modular density at a wavelength of 2.5 aa, and
overlapping the hypothesized sequence position of the e2
extracellular loop. It appears that the dominant sequence
locations of the eigenvector modes of c2 and c4 are not in-
consistent with putative m1AChR allosteric sites in the
research reviewed above. As in these other studies, we have
found that the correspondence is only approximate between
the eigenvector-eigenfunction wavelengths as reﬂected in
their power spectral compared to the mother wavelet scale
transformations (Mandell et al., 2001, 1997a,b,c).
Evaluation of eigenvector hydrophobic mode matched
peptides using a functional assay in m1AChR-transfected
CHO cells: the extracellular acidiﬁcation rate reﬂection of
peptide modiﬁcation of muscarinic ligand-induced cellular
activity.
We conduct initial testing of eigenvector template design
peptides using indices of in vitro cellular and/or in vivo
physiological function before further studies of the effects of
FIGURE 3 (A–C) Isopotential plots of the Morlet continuous one-
dimensional wavelet transformation moduli of the indicated leading
m1AChR eigenfunctions. Sequence position of the wavelet coefﬁcients is
indicated along the x axis and the relative wavelength scale is plotted along
the y axis. We approximate the hydrophobic (mother Morlet wavelet)
eigenfunction wavelength empirically (see text). A graphs the continuous
Morlet wavelet transformation of c1, suggesting modular peaks correspond-
ing to m1AChR’s seven transmembrane segments. B is a graph of the Morlet
wavelet transformation of c2. Densities approximate a mother wavelet
wavelength corresponding to a hydrophobic wavelength of 7–8 aa and
overlap the putative sequence locations of the N-terminal segment, e1 (75–
100), e2 (155–180), and e3 (380–405). These are proposed allosteric sites
in GPCRs in general and m1AChR in particular, and the locations we have
suggested as potential peptide hydrophobic mode-matched interaction sites.
C is a graph of the Morlet wavelet transformation of c4, with a particularly
prominent density at a wavelength of2.5 aa, overlapping the hypothesized
sequence position of the e2 extracellular loop. It appears that the dominant
sequence locations of the eigenvector modes of c2 and c4 are consistent
with putative m1AChR allosteric sites in the literature.
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the most promising peptide on second messenger responses
and radioligand binding. This is consistent with the position
that ‘‘. . .the current emphasis is away from radioligand
binding, toward . . . functional screening . . .’’ for allosteric
ligands (Christopoulos and Kenakin, 2002). For example, we
screened peptides targeting the leading autocovariance
eigenmodes of the human long form D2 dopamine receptor
using microphysiometer monitored (McConnell et al., 1992)
integrated extracellular acidiﬁcation responses (IEAR) of
stably receptor transfected CHO and mouse ﬁbroblast LtK
cells. Those peptides that produced statistically signiﬁcant
augmentation in this functional assay system were studied
more thoroughly in a concentration-response protocol using
the same assay system. Of these, the most robustly active
peptides were examined in vivo, where they activated
dopamine-like brain-behavioral responses in the rat (Mandell
et al., 2003). Now, in our second group of studies with these
peptides, we are exploring their facilitation of the dopamine-
induced inhibition of forskolin-induced cAMP production in
receptor-transfected LtK cells (R. Caceda, B. Kinkead, A.
Mandell, K. Selz, M. Shlesinger, and M. Owens, in
preparation).
The following are similar, initial studies of the modulatory
effects of the peptides listed in Table 4 on muscarinic ligand-
induced changes in IEAR. Data is measured microphysio-
metrically during the ‘‘off’’ times of the pump cycles after
the indicated carbachol alone versus peptide plus carbachol
exposures in m1AChR-transfected CHO-K1 cells. The re-
sults of the experiments reported here will be followed in
later studies by the development of more speciﬁc activity
measures, involving radioligand binding and second mes-
senger involved response measures (e.g., suppression of
forskolin-stimulated cAMP production in muscarinic re-
ceptor transfected cell systems) (Grifﬁn et al., 2003). It
should be noted that high correlations have been reported
between microphysiometric responses to muscarinic ago-
nists and antagonists in muscarinic receptor transfected cell
systems and induced changes in radioligand binding (Wood
et al., 1999), Ca21mobilization measured using a ﬂuorescent
Ca21 ligand (Ikeda et al., 1999), and phosphoinositide
hydrolysis (Baxter et al., 1994). Nonetheless, the results of
the following microphysiometric surveys of eigenvector
template-generated peptide inﬂuences on receptor-mediated
function in m1AChR and m2AChR transfected CHO-K1
cells (Kuo et al., 1993) are to be considered preliminary,
awaiting the results of further studies of less ‘‘downstream’’
indices of second messenger responses.
As reported in the following section, the speciﬁcity of the
actions of the eigenvector template peptides is addressed
microphysiometrically and in two ways: a), within receptor
families, speciﬁcity is suggested by evidence that m1-
targeted, functionally active peptides do not inﬂuence the
activity of hydrophobic-mode-differing (Table 3) m2-trans-
fected CHO IEAR (see below); and b), across receptor
families, speciﬁcity is indicated by studies showing that
D2DAR-targeted and active peptides fail to act on the m1
stably transfected CHO-K1 cell system. Additionally,
m1AChR-targeted and active peptides fail to show functional
activity in human D2DAR stably transfected LtK or CHO
cell systems (Mandell et al., 2003, and see below).
The stably m1AChR and m2AChR transfected
Chinese hamster ovary, CHO-K1, cell systems
and baseline muscarinic agonist-response
microphysiometrically monitored IEAR functions
The stably m1AChR and m2AChR transfected CHO-K1 cell
lines, developed in the Laboratory of Cell Biology, National
Institute of Mental Health, and Laboratory of Molecular
Biology, National Institute of Neurological Disorders and
Stroke, have a long history of successful use in character-
izing receptor-mediated agonist, antagonist, and allosteric
ligand activity (Bonner, 1989; Buckley et al., 1988, 1989;
Dorje et al., 1991; Ellis et al., 1991; Wess et al., 1990). The
human m1AChR and m2AChR, cDNA stably transfected
CHO-K1 cells were prepared using the calcium phosphate
method (Buckley et al., 1989; Chen and Okayama, 1987).
For each cell line, the coding regions of the receptor were
derived from a human cDNA library and inserted into the
expression vector, pcDNA3 (Invitrogen, San Diego, CA).
The CHO-K1 cell lines were maintained in growth medium
consisting of Dulbecco’s modiﬁed Eagle’s medium supple-
mented with 10% fetal calf serum, 1000 units each of
penicillin G and streptomycin, and 2 mM glutamine. Except
for the overnight transfection, cells were incubated in
a humidiﬁed incubator at 378 and 5% CO2. The selection
media contained 250 mg/ml of geneticin.
Muscarinic cholinergic ligand-(carbachol and/or oxotre-
morine) induced changes in the m1 and m2 CHO-K1 cells’
IEAR, in the presence and absence of eigenvector template-
designed peptides, were determined using well-established
microphysiometric functional screening methods for m1, m2,
and other muscarinic receptor transfected cell lines (Baxter
et al., 1994; Ikeda et al., 1999; Kuo et al., 1993; McConnell
et al., 1992). Receptor-mediated changes in overall cellular
glycolytic and respiratory metabolism and/or cellular mem-
brane Na1/H1 exchanges indicate receptor-mediated cellular
activation, and are reﬂected in changes in extracellular
protonic ([H1]) concentrations (McConnell et al., 1992).
[H1] neutralizes the charge on the surface of the silicon
oxide, photocurrent-driven semiconductor sensor and re-
duces the potential-driven current conductance at a rate
linearly related to the rate of extracellular [H1] production.
That is, dmV=dt ¼ ð1Þd½H1=dt:
For typical experiments, capsule cups containing from 1.5
or 2.5 3 105 cells were placed in the sensor chambers and
perfused with low buffering Dulbecco’s modiﬁed Eagle’s
medium with culture grade 0.1% bovine serum albumin at
a pump rate approximating 200 ml/min. This cell number
was chosen, stabilizing the baseline timed signal at 150
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mV/s, empirically optimizing the trade-off between receptor-
mediated cellular response sensitivity and preparation
stability (i.e., avoiding cell damage secondary to excessive
acid buildup in the ‘‘pump off’’ ligand exposure periods).
The 2-min pump cycle consisted of a 30-s off period,
allowing measurable rates of decrease in current, the con-
ductance linearly correlated with rates of extracellular [H1]
production. This was followed by a 60 or 40 s washout,
respectively, with 200 ml/min ﬂow across the cells in a 1.4 ml
volume capsule. After stabilization of the baseline extracel-
lular acidiﬁcation rates, half of the chambers were exposed
to eigenvector template-designed peptides in medium for 12
min (six 2-min cycles) whereas the remaining chambers
received only medium. All chambers were then exposed for
80 s to freshly prepared carbachol, 1 mM/L (approximating
its EC50 in the m1AChR-transfected CHO system). After
a 30-min drug-free perfusion period, allowing a return to the
baseline extracellular acidiﬁcation rates, the procedure was
repeated with the conditions in each chamber reversed. In
this way, each capsule cup/chamber/pump system served as
its own control. We have found that individual sample
chambers can be treated multiple times over a 6–8 h period
without signiﬁcant degradation or drift.
Fig. 4 is a graph of the mean and standard errors of the
carbachol concentration-response curves from two typical
data sets from IEAR data sets, n ¼ 4/ per point. Again, these
represent [H1] collection during off times of the pump
cycles. The two curves differ by 10 s in time of stably
m1AChR-transfected CHO-K1 cell line exposure to the
muscarinic ligand. As noted above, preliminary experiments
have indicated that the carbachol EC50 in this preparation is
;106 M. The sigmoid IEAR functions to carbachol
(observed also after the muscarinic agent, oxotremorine, at
its EC50 of 500 nM in this preparation, not shown) and the
expected amplitude response to changing time of exposure
are consistent with expectations.
The ‘‘box-and-whiskers’’ plot in Fig. 5 represents the
results of studies in the above-described receptor-transfected
cell system demonstrating the anticipated microphysiometric
results of blocking carbachol-induced receptor-mediated
actions by atropine, 250 nM. This is the concentration of
atropine used in previous studies of muscarinic receptor
binding assays (Owens et al., 1997). It antagonized the 1.1
mM carbachol-induced increase in IEAR response compared
with untreated control levels. This inhibition was reversed by
1 h of washout by perfusion of medium alone and re-
exposure to 1.1 mM carbachol. In Fig. 5, the horizontal line
within each box represents median values, the vertical
borders of the box represent the 25th and 75th percentiles,
and the lower and upper horizontal bounds of the
‘‘whiskers’’ encompass the entire range of observed values,
n ¼ 7 per point.
Fig. 6 is a graph of the carbachol IEAR concentration-
response functions in the stably m2AChR transfected CHO-
K1 cells line at three levels of cell number per capsule cup,
1.25, 1.50, and 2.50 3 105, respectively. Mean and
standard errors are shown, n ¼ 8 or 14 per point. The ﬁgure
demonstrates the expected amplitude sensitivity to increas-
FIGURE 4 Mean and standard errors of the carbachol concentration-
response curves from two typical integrated extracellular acidiﬁcation
responses, IEAR, data sets, n ¼ 4 per point. [H1] is collected during off
times of the microphysiometer pump cycles. The top curve results from the
exposure of a stably m1AChR transfected CHO-K1 cell line to the
muscarinic ligand carbachol for 70 s. The bottom curve results from a 60-s
exposure time in the same system. Experiments have shown the carbachol
EC50 in this system to be106 M. The expected sigmoidal IEAR functions
to carbachol and an appropriate amplitude response to changing time of
exposure is demonstrated. Similar observations were made after the
introduction of the muscarinic agent, oxytremorine, at EC50 (500 nM) in
this preparation.
FIGURE 5 ‘‘Box-and-whiskers’’ plot showing the results of studies in
a human m1AChR stably transfected CHO-K1 cell system, demonstrating
the anticipated microphysiometric results of blocking carbachol-induced
receptor-mediated actions by 250 nM atropine. This is the concentration of
atropine used in previous studies of muscarinic receptor binding assays (see
text). The 1.1 mM carbachol-induced increase in IEAR, compared with
untreated control levels, was antagonized by atropine. This inhibition was
then reversed by a 1-h perfusion washout with medium alone and re-
exposure to 1.1 mM carbachol, n ¼ 7 per point. The horizontal line within
each box represents the median value, the vertical borders of the box
represent the 25th and 75th percentiles, and the lower and upper bounds of
the ‘‘whiskers’’ demarcate the range of observed values.
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ing receptor transfected cell numbers. All three functions
manifest the same approximate EC50, and similar carbachol-
induced, quasisigmoid concentration-response forms. The
observed ‘‘cooperative’’ sigmoid shape of the functions are
expected in GPCR-mediated functional activity with the
potential for allosteric interactions, allosteric here meaning
the engagement of the ligand at some site in the receptor
‘‘other’’ than the orthosteric, active site (Christopoulos and
Kenakin, 2002; Hall, 2000).
Muscarinic cholinergic GPCRs with the potential for
allosteric regulation can be inﬂuenced at receptor-active-
orthosteric (carbachol) sites, receptor-G-protein coupling
sites, and receptor-allosteric sites (Christopoulos and
Kenakin, 2002; Christopoulos et al., 1998; Hall, 2000).
The discovery and targeting of the latter is the general goal of
our algorithmic design program. As noted above, receptor-
allosteric sites may be no more than an ‘‘. . . accessory
domain normally serving structural roles . . . it is only with
the discovery of exogenous ligands that recognize these
domains that allosteric modulation of receptor function
becomes biologically relevant . . . .’’
Screening hydrophobic eigenvector-designed
peptides for modulatory inﬂuences on
carbachol-induced changes in
m1AChR-transfected CHO cells’ IEAR
Table 4 (top) summarizes the results of a multitude of
experiments screening m1AChR-targeted peptides for in-
direct agonist/antagonist effects and for their capacities to
modify the effects of carbachol on human m1AChR-
transfected CHO-K1 cells. Indirect agonist effects are
examined as 106 M peptide in buffer versus buffer alone.
Modulatory effects are evaluated using 106 M peptide plus
106 M carbachol compared with the effect of 106 M
carbachol alone. N¼ 8 pairs per comparison, and ns (i.e., not
signiﬁcant)[ p[0.05; *[ 0.05$ p[0.01; **[ 0.01$ p
[ 0.001; and *** [ p\ 0.001. Whereas only one of the
peptides (FSFQ. . .) acted as an indirect agonist, 5 of the 10
(FSFQ. . ., FSFG. . ., ITFT. . ., ISFN. . ., and FNLS. . .)
demonstrated 1 mM peptide-induced augmentation of the
m1AChR-mediated, 1 mM carbachol-evoked increase in in-
tegrated [H1] production rates.
Small Kolmogorov-Smirnov distances in the data distri-
butions (computed but not shown) justiﬁed the assumption
of distributional normality and the use of t-tests of statistical
signiﬁcances of the observed differences in the data (Hoel,
1971). Recall that the integration of the rates of decrement in
potential in microvolts over the off/collection portions of the
pump cycles are linearly related to the rate of increment in
[H1].
Table 4 (bottom) is a graph in which solid squares
indicate physiologically active peptides and open circles
signify peptides that showed no signiﬁcant activity in Table
4 (top). Their order is dictated by their mean amino acid
side-chain pKas. The physiologically inactive LNYQ. . .,
containing two basic lysines, is represented by the open
circle to the right of the diagram (bottom). The four more
acidic inactive peptides are represented by open circles on
the left of the diagram. Of the peptides in Table 4 (top), the
eigenvector template-designed peptides with mean amino
acid side-chain pKa values of between 7.4 and 7.9 were
statistically signiﬁcantly active, whereas peptides with mean
amino acid pKas outside that range were not. A deﬁnitive
statement concerning the role of average side-chain pKa
values on the efﬁcacy of eigenvector template-designed
peptides in the muscarinic and other systems has yet to be
systematically addressed. However, it is known that
proteins as polyampholytes manifest anisotropic charge
distributions such that macromolecularly local pH values
can differ from that of the global assay system, and that this
local variability can play a role in intermolecular recogni-
tion (Daune, 1998).
To estimate the relative probability of the de novo peptide
results in Table 4, we compare our ﬁndings with the results
of random and permutative peptide library searches. We
assume that high through-put screening of a 200,000–
300,000 component random peptide library may be expected
to generated 2–4 ‘‘hits’’ (Guner, 1999; Spencer, 1998). Even
using the more optimistic Bayesian prior assumption that
a survey of a random peptide library would have an
expectancy of as many as 5 active peptides per 100,000
candidates, i.e., p(B) ¼ 0.00005, the probability of the
observed rate of modulatory activity (Table 4), p(A) ¼ 0.5,
FIGURE 6 Carbachol IEAR concentration-response functions in the
stably m2AChR transfected CHO-K1 cell line at three levels of cell number
per capsule cup, 1.25, 1.50, and 2.50 3 105, respectively. Mean and
standard errors are shown, n ¼ 8 or 14 per point. The ﬁgure demonstrates
the expected amplitude sensitivity to increasing receptor-transfected cell
number. All three functions manifest the same approximate EC50 and similar
carbachol-induced, concentration-response forms.
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would be of order pðAjBÞpðBÞ=pðAÞ ¼ 0:0000253
0:0005=0:5 ¼ 0:253 108 (Cox and Hinkley, 1974).
Some kinetic characteristics of the modulatory
actions of a representative eigenvector peptide
on carbachol-induced increases in stably
m1AChR-transfected CHO-K1 cells’ IEAR
Fig. 7 is a graph of the mean and standard errors for
carbachol concentration-response functions at 30 nM,
approximating threshold concentration of FSFQ. . .; n ¼ 4
pairs per point, in units of averaged IEAR (i.e., integrated
rates of decrement in microvolts equals integrated rates of
increment in [H1]). The effects of carbachol alone are
compared with those of 30 nM FSFQ. . . plus carbachol.
Again, each chamber/capsule/sensor acted as its own control.
Fig. 7 demonstrates the expected peptide-induced, left-shift,
and amplitude increase by a low concentration of FSFQ. . . .
Although radioligand binding assays are considered to be the
most direct way to visualize and quantify allosteric
interactions with GPCRs, current GPCR allosteric theory,
including that involving muscarinic receptors, suggests that
functional assays can also be used to demonstrate allosteric
effects (Christopoulos and Kenakin, 2002), for example, the
allosteric effects of gallamine on muscarinic agonist
concentration response curves in rat trachea (Kennakin and Boselli, 1989). Whereas indirect antagonism and negative
cooperativity may be more difﬁcult to demonstrate, often
misinterpreted as competitive antagonism, ‘‘. . . in the case of
(apparent) positive cooperativity, the ascription of an
allosteric mechanism to the experimental data would be
relatively straightforward because the agonist curves would
be displaced to the left of the control agonist curve’’
(Christopoulos and Kenakin, 2002).
Fig. 8 addresses the concentration-response behavior of
the putative positive allosteric inﬂuence of FSFQ. . . . It
shows the mean and standard errors of the IEAR of an
FSFQ. . . concentration-response function of the positive
modulatory effect of FSFQ. . . plus carbachol compared with
the effect of a relatively low (30 nM) concentration of
carbachol alone, n ¼ 4 pairs per point. This asymptotic
peptide ligand-induced sigmoid function is consistent with
the concentration-response behavior of a positive allosteric
modulator of muscarinic and other GPCRs (Christopoulos
and Kenakin, 2002; Hall, 2000). These results suggest
FIGURE 7 Mean and standard errors for carbachol concentration-re-
sponse functions at a 30 nM, approximating the threshold concentration of
FSFQ. . . , n¼ 4 pairs per point. The effects of carbachol alone are compared
with those of 30nM FSFQ. . . plus carbachol in arbitrary units reﬂecting the
relative integrated rate of extracellular proton [H1] production, measured as
the inverse rate of decrement in microvolt potential. Again, each chamber/
capsule/sensor acted as its own control. The ﬁgure demonstrates the
expected peptide-induced, left-shift, and amplitude increase by a low
concentration of FSFQ. . . , suggesting a positive cooperative allosteric
mechanism (see text).
FIGURE 8 Concentration-response behavior of the putative positive
allosteric inﬂuence of FSFQ. . . . An FSFQ. . . concentration-response
function of the positive modulatory effect of FSFQ. . . plus carbachol was
compared with the effect of a relatively low (30 nM) concentration of
carbachol alone. Mean and standard errors of the IEAR of the FSFQ. . . plus
carbachol condition are represented as a percent of the carbachol alone
condition, n ¼ 4 pairs per point. The asymptotic FSFQ. . . function is
consistent with the concentration-response behavior of a positive allosteric
modulator. The EC50 of the peptide effect 300 nM (see text).
TABLE 5 Normalized difference in carbachol versus carbachol
1 peptide hill slopes across FSFQ. . . concentrations
[FSFQ. . .] (HSC1P  HSC)/HSC
10 nM 7029
30 nM 3707
100 nM .4054
300 nM 1.3536
1 mM 3.5696
3 mM 1.2511
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an allosteric EC50 for FSFQ. . . of ;300 nM (i.e., the
concentration of peptide that produces half-maximal effect of
peptide allosteric modulator (Ehlert, 1988)).
The Hill slope or Hill number, HS or nH, is an index
frequently used for quantiﬁcation of the amount of kinetic
cooperativity in a ligand/receptor system. It is an exponent
reﬂecting the slope of the part of the concentration-rate
response function encompassing the middle 50% saturation
region (usually studied between 10% and 90% of the
maximal effect) of the ligand concentration versus response
plot (Ferscht, 1985; Goldbeter and Koshland, 1981; Lauffen-
burger and Linderman, 1993; Limbird, 1986), and is without
established physical bases (Lauffenburger and Linderman,
1993). The higher the value of HS, the greater is said to be
the amount or degree of cooperativity. We compute the best-
ﬁt HS to a series of real data concentration-response
functions representing the effects of the indicated range of
ﬁxed FSFQ. . . concentrations in Table 5, as examined across
the range of carbachol concentrations used in the study in
Fig. 7. Table 5 summarizes the results of these studies in
which, as noted, the Hill slope is presented as the normalized
difference in HS between the two treatment conditions,
carbachol plus peptide, C 1 P, and carbachol alone, C, (i.e.,
(HSC1P – HSC)/HSC) at increasing ﬁxed FSFQ. . . concen-
trations. The real data functions were used to compute best-
ﬁt HS values as in an idealized cooperative sigmoid curve,
½CHS=11½CHS:
Table 5 documents a peptide-induced increase in the
normalized HS difference with increasing concentration of
FSFQ. . .. This is consistent with an FSFQ. . .-induced,
concentration-dependent increase in cooperativity with
increasing peptide levels, from 10 nM to 1 mM. Note that
the normalized HS difference at higher peptide concentration
approaches a no-difference asymptote at 3 mM. Here, as in
Fig. 8, an estimate of the positive cooperative allosteric EC50
of FSFQ. . . appears to be 300 nM.
Two sources of evidence for GPCR-targeted,
modulatory eigenvector-templated peptide
hydrophobic eigenvector mode speciﬁcity
‘‘Within family’’ comparisons of peptide actions on
m1AChR- versus m2AChR-mediated cellular activity
We employed the same microphysiometric protocol de-
scribed above, with 2.53 105 m2AChR-transfected CHO-
K1 cells per capsule cup. Recall that m1AChR and m2AChR
differed in their dominant hydrophobic eigenmodes (Table
FIGURE 10 Previous algorithmic pep-
tide design studies targeting the human
long form D2 dopamine receptor, D2DAR,
have shown the peptides ERNR. . . and
SHQR. . . to be robust indirect agonist
and/or positive allosteric modulators of
dopamine-induced increases in the IEAR
in D2DAR-transfec as distributionally
weighted LtK and CHO cell systems
(Mandell et al., 2003). The hydrophobic
eigenmodes of the dopamine D2DAR are
distinct from those of the m1AChR. Neither
1 mM ERNR. . . nor 1 mM SHQR. . . had
signiﬁcant effects on the 1 mM carbachol
activation of the m1AChR-transfected
CHO-K1 cells.
FIGURE 9 IEAR of the muscarinic ago-
nists, 3 mM carbachol or 500 nM oxotre-
morine, on stably m2AChR transfected
CHO cells. Both agonists were tested at
their approximate EC50 values in this m2
receptor-transfected cell system, and were
studied in the absence and presence of 1 mM
of the m1 receptor active FSFQ. . ., n¼ 6 for
each bar. No signiﬁcant peptide effects on
either of the muscarinic agent-induced
increases in units of IEAR in the hydropho-
bic eigenvector mode differing m2 (Table 3)
transfected CHO-K1 system were observed.
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3). Fig. 9 is a graph of the results of these experiments, in
which the muscarinic agonists, 3 mM carbachol or 500 nM
oxotremorine (both at their approximate EC50s in this m2
receptor-transfected cell system) were studied in the absence
and presence of 1 mM of the m1 receptor active FSFQ. . .,
n ¼ 6 for each bar. No signiﬁcant peptide effects on either
of the muscarinic agent-induced increases in units of IEAR
in the hydrophobic eigenvector mode differing m2 (Table 3)
transfected CHO-K1 system were observed. This ﬁnding is
consistent with our hypothesis that hydrophobic autocovar-
iance eigenvector mode speciﬁcity within the muscarinic
receptor family appears to be of physiological signiﬁcance
with respect to peptide-receptor signaling.
‘‘Across family’’ comparisons of D2 dopamine receptor,
D2DAR, active eigenvector peptide actions on
m1AChR-transfected CHO-K1 cells and m1AChR
active eigenvector peptides on D2DAR-transfected
CHO-K1 and (mouse ﬁbroblast) LtK cells
In previous algorithmic peptide design studies targeting the
human long form D2 dopamine receptor, ERNR. . . and
SHQR. . . were among the strongest indirect agonist and/or
positive allosteric modulators of dopamine-induced in-
creases in the IEAR in D2DAR-transfected LtK and CHO
cell systems (Mandell et al., 2003). Their retro-inverso
analogs (containing the same eigenvector modes as
ERNR. . . and SHQR. . .), when administered bilaterally in
0.5 nmol into rats’ nucleus accumbens, generated both
amphetamine-like increases in exploratory behavior and
reductions of prepulse inhibition (Mandell et al., 2003). Note
that neither 1 mM ERNR. . . nor 1 mM SHQR. . . had
signiﬁcant effects on the 1 mM carbachol activation of the
m1AChR-transfected CHO-K1 cells (Fig. 10).
Fig. 11, in studies of the inverse condition to that of Fig.
10, shows the effects of 1 mM of m1AChR-targeted and
active peptides, FSFQ. . . or ITFT. . . on D2DAR-transfected
CHO-K1 and LtK cells. Neither m1AChR targeted de novo
peptide produced statistically signiﬁcant modulatory effects
on 1 mM dopamine-induced increases in IEAR in either cell
system, n ¼ 6 or 8 per bar.
In the context of mode speciﬁcity, it is important to recall
precisely which mode representation is being discussed. It is
the leading hydrophobic autocovariance matrix eigenvec-
tor(s) (as in Fig. 2 E), and not the statistical wavelength
approximations by their eigenvector/eigenfunction’s maxi-
mum entropy power spectra (as in Fig. 2, B and D), that most
speciﬁcally represent what we regard as the operative
signaling hydrophobic modes. Given this, the ﬁndings of
across D2DAR and m1AChR families comparison of Figs.
10 and 11 (Mandell et al., 2003), along with the m1AChR
versus m2AChR within receptor family comparisons of
Table 3 and Fig. 9, are consistent with our hypothesis that
hydrophobic eigenvector mode-matching speciﬁcity can
play an important role in peptide-receptor signaling (Mandell
et al., 1997c).
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